Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel): A first-in-human phase 1/2 trial in patients with advanced solid tumours
Fields of Study & Subjects
Dendrimers and Hyperbranched Polymers
Nanoparticle-Based Drug Delivery
Cancer Research and Treatment
Publication details
- Journal / source
- European Journal of Cancer
- Publisher
- Elsevier BV
- Volume
- 242
- Pages
- 116821–116821
- Publication date
- 22 May 2026
- Language
- EN